<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20261012071397N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-16</date_registration>
      <primary_sponsor>Shahed University</primary_sponsor>
      <public_title>Exploring the Lived Experiences of Women with Husbands Suffering from Premature Ejaculation: Improvement, Feasibility, and Efficacy of an Individual Cognitive-Behavioral Treatment Package into a Couple-Oriented Package Based on the Findings of a Qualitative Study</public_title>
      <acronym></acronym>
      <scientific_title>Exploring the Lived Experiences of Women with Husbands Suffering from Premature Ejaculation: Improvement, Feasibility, and Efficacy of an Individual Cognitive-Behavioral Treatment Package into a Couple-Oriented Package Based on the Findings of a Qualitative Study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2027-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>8</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/94009</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Education/Guidance, Other design features: Unique Design Features of the Study:   1. Multi-Phase Design: This study consists of four distinct phases: (a) a qualitative phenomenological study exploring the lived experiences of women with husbands suffering from premature ejaculation; (b) development and improvement of an individual CBT package into a couple-oriented package based on qualitative findings; (c) feasibility assessment of the developed package based on experts', therapist's, and couples' opinions; (d) efficacy evaluation of the final package using a single-case experimental design. 2.   Single-Case Experimental Design (SCED): The fourth phase employs a single-case design with multiple baselines. In this design, each couple serves as their own control, and data are collected during baseline, intervention, and follow-up phases. Classical randomization is not used; instead, phase assignment is based on baseline scheduling.  3.  Couple-Oriented Nature of the Intervention: Unlike conventional individual- and symptom-focused treatments for premature ejaculation, this study designs a couple-oriented intervention, actively involving wives in treatment and addressing women's sexual needs and expectations. This approach is based on Phase 1 qualitative findings and women's lived experiences.   4. Mixed-Methods Approach: The present study employs a mixed-methods approach, in which the qualitative findings of the first phase inform the development of the treatment package in the second phase, which is then evaluated quantitatively in the third and fourth phases (feasibility and single-case).   5. Absence of Full Blinding: Due to the nature of the psychological intervention (couple-oriented CBT), full blinding of participants and therapists is not feasible. 6.Presence of a Male Research Collaborator: Given cultural considerations and the necessity of observing religious boundaries in sexual health interventions, male-specific sessions and joint couple sessions are conducted with the presence of a male therapist (Dr. Seyed Kazem Foroutan, Urologist and Head of the Family Health Clinic at Shahed University.    7.Emphasis on Theoretical Saturation in the Qualitative Study: The sample size in the first study is determined based on theoretical saturation (estimated 12–20 participants), and purposive sampling is employed.  8.  Limited Sample Size in the Efficacy Study: The fourth study is conducted with 4 couples (plus 1 pilot couple), which is consistent with the nature of the single-case design and the goal of in-depth examination of the change process.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Premature ejaculation.</hc_freetext>
      <i_freetext>**Intervention name:** Couple-oriented cognitive-behavioral therapy based on qualitative findings for premature ejaculation. **Intervention type:** Psychological – Cognitive/Behavioral (CBT). **Therapeutic method:** This intervention is based on a cognitive-behavioral treatment package initially developed in an individual format and then improved into a couple-oriented package using qualitative research findings (women's lived experiences) and active participation of couples. The main approach is a combination of cognitive techniques (correcting dysfunctional sexual thoughts and beliefs), behavioral techniques (exposure exercises, stop-start, communication), and couple-oriented techniques (increasing intimacy, communication skills, attention to women's sexual needs). **Number and duration of sessions:** Total sessions: 10. Duration per session: 60 to 90 minutes. Course duration: 10 weeks (one session per week). **Session content and structure:** Includes cognitive-behavioral education on premature ejaculation, ejaculation control techniques (stop-start, squeeze), anxiety management, and correcting dysfunctional sexual beliefs. Introductory education on sexual anatomy and physiology of men and women, communication and sexual dialogue skills, foreplay and intimacy exercises, attention to women's sexual needs and expectations, and couple-based homework. **Setting:** Family Health Clinic, Shahed University. **Equipment:** Private counseling room, printed questionnaires and worksheets, and educational materials. **Homework and worksheets:** Couple-based homework and in-session/out-of-session worksheets..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Primary and Secondary  Outcome Data
Qualitative Data (Interviews)
Protocol and Treatment Package
Analytical Data and Results

When:
Access start date: 6 months after publication of the main results in a reputable scientific journal.

Time frame: Unlimited.

To whom:
Academic and Scientific Institution Researchers
Clinical Specialists and Therapists
Ethics Committees and Scientific Reviewers

Conditions:
Request Conditions:

    Official request form + introduction letter + practice license + ethics approval + confidentiality agreement + DUA.

Permitted analyses: Descriptive, inferential, statistical, qualitative.

Not permitted analyses: Commercial, re-identification, destructive.

Permitted use of documentation: Scientific, educational, clinical with citation.

Not permitted use: Reproduction, sale, ownership claims, commercial use.

Governing mechanisms: PI supervision, reporting, citation, no third-party transfer, specified validity period.

Qualitative data: Key quotes only, without identifying information.

Where to obtain:
Applicants may request access to data or documentation through the following channels, in order of priority:

1. Principal Investigator (First Priority):

    Name: Zahra Khaksari

    Role: Principal Investigator

    Email: zahra.khaksari@shahed.ac.ir

    Mobile:00989046466233

    Postal Address: Tehran, Palestine Street, Italia Street, Next to Shahid Mostafa Khomeini Hospital, Family Health Clinic, Shahed University

2. Supervisor (Second Priority):

    Name: Dr. Seyed Kazem Foroutan

    Role: Supervisor, Urologist

    Email: foroutan@shahed.ac.ir

    Postal Address: Tehran, Beginning of Tehran-Qom Freeway, Opposite the Holy Shrine of Imam Khomeini, Shahed University, Family Health Clinic

How to obtain:
Request Process:

    Submit form + introduction letter (1 week)

    PI review (1-2 weeks)

    Ethics approval  (2-4 weeks)

    Sign confidentiality agreement + DUA (1 week)

    Data preparation and delivery (1-2 weeks)

    Post-use reporting

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Khaksari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 9, Italia Street, Palestine Street, Keshavarz Boulevard, Vali-e-Asr Square, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1416643491</zip>
        <telephone>+98 21 8898 5918</telephone>
        <email>zahra.khaksari@shahed.ac.ir</email>
        <affiliation>Shahed University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyed Kazem foroutan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 9, Italia Street, Palestine Street, Keshavarz Boulevard, Vali-e-Asr Square, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1416643491</zip>
        <telephone>+98 21 8898 5918</telephone>
        <email>foroutan@shahed.ac.ir</email>
        <affiliation>Shahed University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Couples with a husband diagnosed with premature ejaculation
Confirmed diagnosis of the husband's premature ejaculation based on clinical interview and the PEDT questionnaire
Absence of major psychiatric disorders (based on SCL-27) and personality disorders (based on PID-5-BF) in either spouse
Absence of major marital conflicts
No use of psychiatric medications affecting premature ejaculation within the past three months
Willingness to participate and ability to communicate verbally
At least two years of marital life
Age 25 years and older for both spouses</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Presence of other sexual dysfunctions (e.g., erectile dysfunction) requiring independent treatment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F52.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Premature ejaculation</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>**Intervention name:** Couple-oriented cognitive-behavioral therapy based on qualitative findings for premature ejaculation. **Intervention type:** Psychological – Cognitive/Behavioral (CBT). **Therapeutic method:** This intervention is based on a cognitive-behavioral treatment package initially developed in an individual format and then improved into a couple-oriented package using qualitative research findings (women's lived experiences) and active participation of couples. The main approach is a combination of cognitive techniques (correcting dysfunctional sexual thoughts and beliefs), behavioral techniques (exposure exercises, stop-start, communication), and couple-oriented techniques (increasing intimacy, communication skills, attention to women's sexual needs). **Number and duration of sessions:** Total sessions: 10. Duration per session: 60 to 90 minutes. Course duration: 10 weeks (one session per week). **Session content and structure:** Includes cognitive-behavioral education on premature ejaculation, ejaculation control techniques (stop-start, squeeze), anxiety management, and correcting dysfunctional sexual beliefs. Introductory education on sexual anatomy and physiology of men and women, communication and sexual dialogue skills, foreplay and intimacy exercises, attention to women's sexual needs and expectations, and couple-based homework. **Setting:** Family Health Clinic, Shahed University. **Equipment:** Private counseling room, printed questionnaires and worksheets, and educational materials. **Homework and worksheets:** Couple-based homework and in-session/out-of-session worksheets.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity of premature ejaculation symptoms in men. Timepoint: Severity of premature ejaculation symptoms in men is measured at the following time points: 1.   Baseline: At least three measurements before the start of the intervention, at one-week intervals, to establish the baseline trend and symptom stability.   2. During Intervention: After the start of the intervention, assessments are conducted at the end of sessions 3, 6, and 9 (i.e., weeks 3, 6, and 9, respectively).  3.  Post-Intervention (Post-test): Immediately after the completion of the 10-week sessions.    Follow-up: 1.5 months after the end of the intervention. Method of measurement: Tool: Premature Ejaculation Diagnostic Tool (PEDT) and Intravaginal Ejaculatory Latency Time (IELT) measurement.Method: The PEDT questionnaire is completed by the affected man. The IELT is measured based on the couples' self-report.</prim_outcome>
      <prim_outcome>Men's Sexual Quality of Life. Timepoint: Men's sexual quality of life is measured at the following time points:1.   Baseline: At least three measurements before the start of the intervention, at one-week intervals, to establish the baseline trend and symptom stability.   2. During Intervention: After the start of the intervention, assessments are conducted at the end of sessions 3, 6, and 9 (i.e., weeks 3, 6, and 9, respectively).  3.  Post-Intervention (Post-test): Immediately after the completion of the 10-week sessions.    Follow-up: 1.5 months after the end of the intervention. Method of measurement: Sexual Quality of Life Questionnaire for Men (SQOL-M) by Abraham et al. (2008).</prim_outcome>
      <prim_outcome>Couples' sexual satisfaction. Timepoint: Couples' sexual satisfaction is measured at the following time points:1.   Baseline: At least three measurements before the start of the intervention, at one-week intervals, to establish the baseline trend and symptom stability.    2. During Intervention: After the start of the intervention, assessments are conducted at the end of sessions 3, 6, and 9 (i.e., weeks 3, 6, and 9, respectively).  3.  Post-Intervention (Post-test): Immediately after the completion of the 10-week sessions.    Follow-up: 1.5 months after the end of the intervention. Method of measurement: Golombok-Rust Sexual Satisfaction Questionnaire.</prim_outcome>
      <prim_outcome>Couples' marital adjustment. Timepoint: Couples' marital adjustment is measured at the following time points:1.   Baseline: At least three measurements before the start of the intervention, at one-week intervals, to establish the baseline trend and symptom stability.  2. During Intervention: After the start of the intervention, assessments are conducted at the end of sessions 3, 6, and 9 (i.e., weeks 3, 6, and 9, respectively). 3.  Post-Intervention (Post-test): Immediately after the completion of the 10-week sessions.    Follow-up: 1.5 months after the end of the intervention. Method of measurement: Revised Dyadic Adjustment Scale (RDAS) by Busby et al.</prim_outcome>
      <prim_outcome>Female sexual function. Timepoint: Female sexual function is measured at the following time points:1.   Baseline: At least three measurements before the start of the intervention, at one-week intervals, to establish the baseline trend and symptom stability.   2. During Intervention: After the start of the intervention, assessments are conducted at the end of sessions 3, 6, and 9 (i.e., weeks 3, 6, and 9, respectively).3.  Post-Intervention (Post-test): Immediately after the completion of the 10-week sessions.    Follow-up: 1.5 months after the end of the intervention. Method of measurement: Female Sexual Function Index (FSFI) self-report questionnaire by Rosen et al.</prim_outcome>
      <prim_outcome>Sexual Quality of Life-Female. Timepoint: Sexual Quality of Life-Female is measured at the following time points:1.   Baseline: At least three measurements before the start of the intervention, at one-week intervals, to establish the baseline trend and symptom stability.   2. During Intervention: After the start of the intervention, assessments are conducted at the end of sessions 3, 6, and 9 (i.e., weeks 3, 6, and 9, respectively). 3.  Post-Intervention (Post-test): Immediately after the completion of the 10-week sessions.    Follow-up: 1.5 months after the end of the intervention. Method of measurement: Sexual Quality of Life-Female questionnaire (SQOL-F) by Symonds et al (2005).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahed University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-09-01</approval_date>
        <contact_name>Ethics committee of Shahd University of Medical Sciences</contact_name>
        <contact_address>Khalij-e Fars Highway (Beginning of Tehran-Qom Freeway), Opposite the Holy Shrine of Imam Khomeini, Shahed University Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
